Buy Divi's Laboratories Ltd. at a price target of Rs 660.0 and a stoploss at Rs 618.4 from entry point

Perarivalan had referred to the inquiry report of the Jain Commission which formed the basis for TADA court's decision for probing individu...

The regulator’s key objective is to bring traditional products on par with Ulips in terms of charges,” says Arvind Laddha, Vantage Insuranc...